Page last updated: 2024-08-23

sufentanil and Visceral Pain

sufentanil has been researched along with Visceral Pain in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jiang, YM; Li, WW; Liu, YN; Shi, R; Wang, ZW; Zheng, B1
Dong, CS; Lu, Q; Luo, C; Ma, X; Sun, H; Sun, P; Yu, JM1
An, Y; Chen, X; Huang, J; Li, L; Li, Z; Wang, P; Wang, T; Xiao, W; Zhao, L1

Trials

2 trial(s) available for sufentanil and Visceral Pain

ArticleYear
The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus.
    Medicine, 2018, Volume: 97, Issue:38

    Topics: Adjuvants, Anesthesia; Adult; Amides; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Cesarean Section; Cicatrix; Double-Blind Method; Female; Humans; Pregnancy; Prospective Studies; Ropivacaine; Sufentanil; Treatment Outcome; Uterus; Visceral Pain

2018
Preemptive oxycodone is superior to equal dose of sufentanil to reduce visceral pain and inflammatory markers after surgery: a randomized controlled trail.
    BMC anesthesiology, 2019, 06-11, Volume: 19, Issue:1

    Topics: Adult; Analgesics, Opioid; Cholecystectomy, Laparoscopic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation Mediators; Male; Middle Aged; Oxycodone; Pain, Postoperative; Prospective Studies; Sufentanil; Visceral Pain

2019

Other Studies

1 other study(ies) available for sufentanil and Visceral Pain

ArticleYear
Patient-controlled intravenous administration of dexmedetomidine with nalbuphine versus sufentanil for post cesarean delivery analgesia: A retrospective observational study.
    The Kaohsiung journal of medical sciences, 2023, Volume: 39, Issue:7

    Topics: Administration, Intravenous; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Cesarean Section; Dexmedetomidine; Female; Humans; Nalbuphine; Pain, Postoperative; Pregnancy; Sufentanil; Visceral Pain

2023